133 related articles for article (PubMed ID: 32606160)
1. The ABO Blood Group Impacts the Survival of Patients Undergoing Pancreatoduodenectomy for Biliary Tract Cancer.
Mori S; Aoki T; Tago K; Shimizu T; Harada N; Park KH; Sakuraoka Y; Shiraki T; Iso Y; Kubota K
In Vivo; 2020; 34(4):1893-1900. PubMed ID: 32606160
[TBL] [Abstract][Full Text] [Related]
2. Association of ABO blood group with survival following pancreatoduodenectomy for pancreatic ductal adenocarcinoma.
Williams H; Jajja MR; Hashmi SS; Maxwell D; Cardona K; Maithel SK; Russell MC; Sarmiento JM; Winer JH; Kooby DA
HPB (Oxford); 2020 Nov; 22(11):1557-1562. PubMed ID: 32146119
[TBL] [Abstract][Full Text] [Related]
3. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy.
Ikezawa K; Kanai M; Ajiki T; Tsukamoto T; Toyokawa H; Terajima H; Furuyama H; Nagano H; Ikai I; Kuroda N; Awane M; Ochiai T; Takemura S; Miyamoto A; Kume M; Ogawa M; Takeda Y; Taira K; Ioka T
J Hepatobiliary Pancreat Sci; 2014 Feb; 21(2):98-104. PubMed ID: 23798367
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
5. The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer.
Fukumoto K; Taniguchi T; Usami N; Kawaguchi K; Fukui T; Ishiguro F; Nakamura S; Yokoi K
J Epidemiol; 2015; 25(2):110-6. PubMed ID: 25483106
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of fluoropyrimidine-based adjuvant chemotherapy on biliary tract cancer after R0 resection.
Kim YS; Jeong CY; Song HN; Kim TH; Kim HJ; Lee YJ; Hong SC
Chin J Cancer; 2017 Jan; 36(1):9. PubMed ID: 28086990
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy - A multicenter cohort study.
Bolm L; Ohrner K; Nappo G; Rückert F; Zimmermann C; Rau BM; Petrova E; Honselmann KC; Lapshyn H; Bausch D; Weitz J; Sandini M; Keck T; Zerbi A; Distler M; Wellner UF
Pancreatology; 2020 Apr; 20(3):433-441. PubMed ID: 31987649
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Sarcopenia in Patients With Biliary Tract Cancer Undergoing Chemotherapy.
Meguro K; Hosono K; Sato M; Sugimoto Y; Takai Y; Kurita Y; Kanoshima K; Shimizu T; Sakai E; Nakajima A
In Vivo; 2021; 35(5):2909-2915. PubMed ID: 34410986
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
Kim H; Heo MH; Kim JY
BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Features of Surgically-resected Biliary Tract Cancer Following Chemo-radiation Therapy.
Kobayashi S; Gotoh K; Takahashi H; Akita H; Marubashi S; Yamada T; Teshima T; Nishiyama K; Yano M; Ohigashi H; Ishikawa O; Sakon M
Anticancer Res; 2016 Jan; 36(1):335-42. PubMed ID: 26722062
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery.
Akazawa Y; Mizuno S; Fujinami N; Suzuki T; Yoshioka Y; Ochiya T; Nakamoto Y; Nakatsura T
Sci Rep; 2019 Apr; 9(1):5925. PubMed ID: 30976046
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of ABO Blood Groups in Patients with Glioblastoma Multiforme.
Sokmen FC; Karacin C
J Coll Physicians Surg Pak; 2020 Jul; 30(7):713-716. PubMed ID: 32811600
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of differentiation at the invasive front of biliary tract cancer.
Okubo S; Mitsunaga S; Kato Y; Kojima M; Sugimoto M; Gotohda N; Takahashi S; Hayashi R; Konishi M
J Surg Oncol; 2018 May; 117(6):1278-1287. PubMed ID: 29572828
[TBL] [Abstract][Full Text] [Related]
15. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer.
Li H; Zhao T; Ji X; Liang S; Wang Z; Yang Y; Yin J; Wang R
Tumour Biol; 2016 Mar; 37(3):3535-42. PubMed ID: 26453118
[TBL] [Abstract][Full Text] [Related]
16. [Long-Term Prognosis of Patients with Biliary Tract Cancer Undergoing Pancreaticoduodenectomy].
Mizukami A; Kawaida H; Hayashi T; Nakayama T; Matsuoka K; Saito R; Yamamoto A; Takahashi K; Takiguchi K; Hirayama K; Ashizawa N; Shoda K; Shiraishi K; Furuya S; Hosomura N; Akaike H; Kawaguchi Y; Amemiya H; Kono H; Ichikawa D
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1136-1138. PubMed ID: 36281611
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for and clinical findings of liver abscess after biliary-intestinal anastomosis.
Kubo S; Kinoshita H; Hirohashi K; Tanaka H; Tsukamoto T; Kanazawa A
Hepatogastroenterology; 1999; 46(25):116-20. PubMed ID: 10228774
[TBL] [Abstract][Full Text] [Related]
18. A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC).
Ruzzenente A; Iacono C; Conci S; Bertuzzo F; Salvagno G; Ruzzenente O; Campagnaro T; Valdegamberi A; Pachera S; Bagante F; Guglielmi A
Surgery; 2014 Apr; 155(4):633-9. PubMed ID: 24468034
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Characteristics of Advanced Biliary Tract Cancer Using 18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications.
Cho KM; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Oncologist; 2015 Aug; 20(8):926-33. PubMed ID: 26099746
[TBL] [Abstract][Full Text] [Related]
20. Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma.
Chang YT; Hsu C; Jeng YM; Chang MC; Wei SC; Wong JM
J Gastroenterol Hepatol; 2007 Mar; 22(3):389-94. PubMed ID: 17295772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
